Evidence map›Paper›PMID 27431011›Full record

ArticleJournal of pharmaceutical sciences2016

Effect of Biophysical Properties of Phosphatidylserine Particle on Immune Tolerance Induction Toward Factor VIII in a Hemophilia A Mouse Model.

Radha Ramakrishnan, Sathy V Balu-Iyer

Open access · greenAbstract read
In one paragraph

Article in Journal of pharmaceutical sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Radha RamakrishnanDepartment of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, New York 14215.
Sathy V Balu-IyerDepartment of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, New York 14215. Electronic address: svb@buffalo.edu.
University at Buffalo, State University of New York · US

Funding

HL-Development and Pharmacology of novel lipidic rAHF and biotherapeuticsR01HL070227 · NHLBI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI BALU-IYER, SATHY VENKAT · 2002 to 2019
$5.0M
NHLBI NIH HHS R01 HL070227
6 · The paper itself

Abstract

A major complication in the replacement therapy of Factor VIII (FVIII) for Hemophilia A is the development of unwanted immune responses. Previous studies from our laboratory have shown that pretreatment of FVIII in the presence of phosphatidylserine (PS) resulted in hyporesponsiveness to subsequent administration of FVIII alone, due to the ability of PS to convert an immunogen to a tolerogen. We investigated the importance of biophysical properties of PS liposomes on its ability to convert an immunogen to a tolerogen. PS particles were prepared differing in size, protein-lipid topology, lamellarity, and % association to FVIII keeping the composition of the particle same. PS particles were prepared in 2 different sizes with differing biophysical properties: smaller particles in the nanometer range (200 nm) and larger size particles in the micron range (2 μm). Hemophilia A animals treated with both the nanometer and micron size PS particles showed a significant reduction in anti-FVIII antibody titers when compared to animals receiving free FVIII alone. Upon rechallenge with free FVIII animals that received FVIII along with the nanometer size particle continued to show reduced antibody responses. Animals receiving the micron size particle showed a slight increase in titers although they remained significantly lower than the free FVIII treated group. Upon culture with bone marrow derived dendritic cells, the nanometer size particle showed a reduction in CD40 expression and an increase in transforming growth factor-β cytokine production, which was not observed with the micron size particle. These results show that biophysical properties of PS play an important role in tolerance.

Indexed as

Disease Models, AnimalAnimalsFactor VIIIHemophilia AHumansImmune ToleranceInjections, SubcutaneousMiceMice, KnockoutParticle SizePhosphatidylserinesRecombinant ProteinsTreatment OutcomeFactor VIIIPhosphatidylserinesRecombinant Proteinsimmune toleranceimmunologylipidsphosphatidylserineprotein delivery

Identifiers

PMID27431011
PMCPMC5021571
OpenAlexW2486909239

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.